Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

123.96
Delayed Data
As of Jul 31
 +2.26 / +1.86%
Today’s Change
67.18
Today|||52-Week Range
134.26
+25.17%
Year-to-Date

Today’s Trading

Previous close121.70
Today’s open122.00
Day’s range121.81 - 124.14
Volume924,255
Average volume (3 months)1,046,813
Market cap$14.5B
Dividend yield--
Data as of 4:04pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+50.61%
Earnings growth (next 5 years)+18.79%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc+0.05+0.06%
JAZZJazz Pharmaceuticals...+1.86+0.98%
ENDPEndo International P...+1.58+1.84%
ALKSAlkermes Plc+2.49+3.69%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$1.83
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts